Yanglu Chen

1.2k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

Yanglu Chen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yanglu Chen has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Yanglu Chen's work include Drug Transport and Resistance Mechanisms (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and DNA Repair Mechanisms (2 papers). Yanglu Chen is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and DNA Repair Mechanisms (2 papers). Yanglu Chen collaborates with scholars based in United States and China. Yanglu Chen's co-authors include Zhe‐Sheng Chen, Enju Wang, Hui Chao, Liang‐Nian Ji, Pranav Gupta, Leli Zeng, Siobhán Q. Gregg, Agata Smogorzewska, Brooke A. Conti and Priyank Kumar and has published in prestigious journals such as Chemical Society Reviews, Genes & Development and PLoS ONE.

In The Last Decade

Yanglu Chen

8 papers receiving 1.0k citations

Hit Papers

The development of anticancer ruthenium(ii) complexes: fr... 2017 2026 2020 2023 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanglu Chen United States 6 614 484 314 234 179 8 1.0k
Raymond Wai‐Yin Sun China 14 519 0.8× 403 0.8× 247 0.8× 248 1.1× 110 0.6× 15 964
Andreia de Almeida Netherlands 21 516 0.8× 564 1.2× 432 1.4× 146 0.6× 99 0.6× 27 1.1k
Bhabatosh Banik India 16 366 0.6× 261 0.5× 265 0.8× 248 1.1× 155 0.9× 24 845
Zhenlei Zhang China 21 563 0.9× 322 0.7× 299 1.0× 156 0.7× 112 0.6× 36 902
Pengfei Shi China 20 562 0.9× 495 1.0× 484 1.5× 175 0.7× 107 0.6× 49 1.3k
Huayun Shi United Kingdom 16 655 1.1× 612 1.3× 329 1.0× 388 1.7× 321 1.8× 26 1.3k
Peter M. Bruno United States 19 816 1.3× 453 0.9× 847 2.7× 158 0.7× 199 1.1× 25 1.7k
James P. C. Coverdale United Kingdom 17 518 0.8× 577 1.2× 340 1.1× 215 0.9× 146 0.8× 35 1.2k
Jitka Prachařová Czechia 13 433 0.7× 342 0.7× 156 0.5× 185 0.8× 99 0.6× 30 655
Zoufeng Xu China 17 594 1.0× 403 0.8× 355 1.1× 408 1.7× 340 1.9× 23 1.2k

Countries citing papers authored by Yanglu Chen

Since Specialization
Citations

This map shows the geographic impact of Yanglu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanglu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanglu Chen more than expected).

Fields of papers citing papers by Yanglu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanglu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanglu Chen. The network helps show where Yanglu Chen may publish in the future.

Co-authorship network of co-authors of Yanglu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yanglu Chen. A scholar is included among the top collaborators of Yanglu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanglu Chen. Yanglu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Patel, Harsh, Zhuo‐Xun Wu, Yanglu Chen, Letao Bo, & Zhe‐Sheng Chen. (2021). Drug resistance: from bacteria to cancer. Molecular Biomedicine. 2(1). 26 indexed citations
2.
Ma, Xiangyu, Liuya Wei, Zi‐Ning Lei, et al.. (2021). Recent progress on targeting leukemia stem cells. Drug Discovery Today. 26(8). 1904–1913. 10 indexed citations
3.
Chen, Yanglu, et al.. (2021). Facial Acupoints Location using Transfer Learning on Deep Residual Network. 2021 7th International Conference on Computer and Communications (ICCC). 1842–1847. 5 indexed citations
4.
Harb, Amro A., et al.. (2021). Acute Vision Loss From IgG4-Related and Bacterial Rhinosinusitis After COVID-19. JAMA Otolaryngology–Head & Neck Surgery. 147(10). 914–914. 3 indexed citations
5.
Zeng, Leli, Pranav Gupta, Yanglu Chen, et al.. (2017). The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chemical Society Reviews. 46(19). 5771–5804. 876 indexed citations breakdown →
6.
Li, Jun, Priyank Kumar, Nagaraju Anreddy, et al.. (2017). Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies. Oncotarget. 8(55). 93785–93799. 22 indexed citations
7.
Thongthip, Supawat, Marina A. Bellani, Siobhán Q. Gregg, et al.. (2016). Fan1 deficiency results in DNA interstrand cross-link repair defects, enhanced tissue karyomegaly, and organ dysfunction. Genes & Development. 30(6). 645–659. 44 indexed citations
8.
Kumar, Priyank, Kang Chen, Kamlesh Sodani, et al.. (2013). Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar. PLoS ONE. 8(2). e55576–e55576. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026